The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

Sanofi CEO Paul Hudson says, "AI is a huge opportunity, and we can't be deniers." ...

"I think we were contrarians,” Sanofi's chief digital officer Emmanuel Frenehard told Fortune. “I think the contrarians are ...

A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...

Paris: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine ...

HighTower Advisors LLC boosted its position in Sanofi (NASDAQ:SNY – Free Report) by 1.0% during the 3rd quarter, according to ...

Sanofi has reported that the Phase III LUNA 3 trial of rilzabrutinib for the treatment of persistent or chronic immune ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Sanofi reports positive Phase III results for its BTK inhibitor in treating immune thrombocytopenia, demonstrating faster ...

SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...

Sanofi (SNY) says new data from three oral presentations demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly ...